Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/101136
Title: Patients clinical information requirements to apply the STOPP/START criteria
Authors: Carvalho, Rosário
Lavrador, Marta 
Cabral, Ana C. 
Veríssimo, Manuel T. 
Figueiredo, Isabel V. 
Fernandez-Llimos, Fernando 
Castel-Branco, M. Margarida 
Keywords: Aged; Clinical patient information; Drug safety; Inappropriate prescribing; STOPP/START criteria
Issue Date: 29-Oct-2019
Publisher: Springer
Project: info:eu-repo/grantAgreement/FCT/POR_CENTRO/SFRH/BD/123678/2016/PT/Quantificação da carga anticolinérgica como preditor do aparecimento de resultados clínicos negativos no idoso – um contributo para a prática clínica 
metadata.degois.publication.title: International Journal of Clinical Pharmacy
metadata.degois.publication.volume: 41
Abstract: Background The STOPP/START criteria are an explicit tool to detect potentially inappropriate medications (PIMs). Patient clinical information may not be available in all settings. Objective To identify patient clinical information needed to apply the STOPP/START criteria. Setting: Four nursing homes in Portugal. Methods First, a theoretical analysis was performed to identify the patient information required to apply the STOPP/START criteria (v2), according to the following categories: patients’ current medication, medication history (previous medication and duration), medical records (current and past medical conditions), and laboratory test results. A verification of the information requirements was conducted through a cross-sectional study on a nursing home population with patients over 65 years old. Patient's medical records were appraised to extract only demographic data and current medication profiles. Main outcome measure Information requirements of STOPP/ START. Results For only 29 of the 81 STOPP criteria and 1 of the 34 START criteria, a judgment could be made with only the information in the patient’s medication profile. 52 STOPP and 33 START criteria require additional information, (i.e. duration of therapy, previous medication, current, and past medical conditions, and laboratory data). The 208 evaluated persons (87 years; 68.75% female) used 1770 medications, with 989 (55.9%) potentially involved in 1629 STOPP criteria. Sufficient information to judge STOPP criteria was available for only 529 (32.5%) potential STOPP criteria situations, with a positive identification of a STOPP PIM in 397 instances (75.0%). Conclusions Although STOPP/START criteria can be considered a high-level tool to identify PIMs, their use may be compromised in scenarios where access to patients' clinical information is limited.
URI: https://hdl.handle.net/10316/101136
ISSN: 2210-7703
2210-7711
DOI: 10.1007/s11096-019-00920-5
Rights: openAccess
Appears in Collections:FFUC- Artigos em Revistas Internacionais
I&D ICBR - Artigos em Revistas Internacionais

Show full item record

SCOPUSTM   
Citations

12
checked on Nov 4, 2024

WEB OF SCIENCETM
Citations

11
checked on Nov 2, 2024

Page view(s)

140
checked on Nov 5, 2024

Download(s)

161
checked on Nov 5, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.